Efficacy and safety of vigabatrin in patients with tuberous sclerosis complex and infantile epileptic spasm syndrome: a systematic review

CONCLUSIONS: Although all the studies analyzed reported beneficial effects of VGB in TSC patients with IESS, with higher response rates in comparison to non-TSC subjects with IESS, a low level of evidence and high heterogeneity do not guarantee sufficient strength for therapeutic recommendations.PMID:37243682 | DOI:10.1080/14737175.2023.2216385
Source: Expert Review of Neurotherapeutics - Category: Neurology Authors: Source Type: research